Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <i>BRCA1/2</i> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis
Melinda L. Telli(Stanford University), Andrea L. Richardson(Johns Hopkins University), Roisín M. Connolly(Johns Hopkins University), Judy E. Garber(Dana-Farber Cancer Institute), Sunil Badve(Emory University), Charles C. Chu(Stanford University), Joshua J. Gruber(Southwestern Medical Center), Daniel P. Silver(Dana-Farber Cancer Institute), Sylvia Adams(NYU Langone Health), Ryan Bernhisel(Myriad Genetics), Kirsten M. Timms(Myriad (Germany)), Virginia Kaklamani(Northwestern University), Nadine Tung(Beth Israel Deaconess Medical Center), Vered Stearns(Johns Hopkins University), Chris Neff(Myriad Genetics), William J. Gradishar(Northwestern University), James M. Ford(Palo Alto University), Shaveta Vinayak(Roswell Park Comprehensive Cancer Center), Steven J. Isakoff(Harvard University)
Cited by 58
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k